Variations in non-pharmacological anti-infective measures in childhood leukemia - results of an international survey

Haematologica

Volumn 97, Issue 10, 2012, Pages 1548-1552

  Lehrnbecher, Thomas ^a   Aplenc, Richard ^b   Pereira, Fernanda Rivas ^c   Lassaletta, Alvaro ^d   Caselli, Désirée ^e   Kowalczyk, Jerzy ^f   Chisholm, Julia ^g   Sung, Lillian ^h  

^a GOETHE UNIVERSITY   (Germany)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Children's Hospital   (Argentina)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^e UNIVERSITY OF FLORENCE   (Italy)

^f MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Child; Infection; Non pharmacological anti infective measures

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; FACE MASK; FEEDING BEHAVIOR; HEALTH SURVEY; HUMAN; INFECTION; INFECTION RISK; PET ANIMAL; PROPHYLAXIS; SOCIAL BEHAVIOR;

CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; HEALTH SURVEYS; HUMANS; LEUKEMIA, MYELOID, ACUTE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84867267543     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.062885     Document Type: Article

References (19)

1. Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B, et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant. 2008; 41(4): 339-47.
2. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110(10):3532-9.
3. Rungoe C, Malchau EL, Larsen LN, Schroeder H. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazoletrimethoprim (SMX-TMP) prophylaxis. Pediatr Blood Cancer. 2010;55(2): 304-8.
4. Bochennek K, Tramsen L, Schedler N, Becker M, Klingebiel T, Groll AH, et al. Liposomal amphotericin B twice weekly as antifungal prophylaxis in pediatric high risk patients. Clin Microb Infect. 2011;17(12):1868-74.
5. Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR. Prophylactic granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. J Clin Oncol. 2004;22(16):3350-6.
6. Lehrnbecher T, Ethier MC, Zaoutis T, Creutzig U, Gamis A, Reinhardt D, et al. International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol. 2009;147(1):125-8.
7. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, et al. Longterm results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin- Frankfurt-Münster. Leukemia. 2000;14(12): 2205-14.
8. Sander A, Zimmermann M, Dworzak M, Fleischhack G, von Neuhoff C, Reinhardt D, et al. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia. 2010;24(8):1422-8.
9. Hargrave DR, Hann II, Richards SM, Hill FG, Lilleyman JS, Kinsey S, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol. 2001;112(2):293-9.
10. Lehrnbecher T, Laws HJ, Boehm A, Dworzak M, Janssen G, Simon A, et al. Compliance with anti-infective preventive measures: a multicentre survey among paediatric oncology patients. Eur J Cancer. 2008;44(13):1861-5.
11. Moody K, Charlson ME, Finlay J. The neutropenic diet: what's the evidence? J Ped Hematol Oncol. 2002;24(89):717-21.
12. Maschmeyer G, Neuburger S, Fritz L, Böhme A, Penack O, Schwerdtfeger R, et al. A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. Ann Oncol. 2009;20(9):1560-4.
13. Moody K, Finlay J, Mancuso C, Charlson M. Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. J Ped Hematol Oncol. 2006;28(3):126-33.
14. DeMille D, Deming P, Lupinacci P, Jacobs LA. The effect of the neutropenic diet in the outpatient setting: a pilot study. Oncol Nurs Forum. 2006;33(2):337-43.
15. Gardner A, Mattiuzzi G, Faderl S, Borthakur G, Garcia-Manero G, Pierce S, et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol. 2008; 10(35):5684-8.
16. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch- Institut (RKI). Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten. Bundesgesundheitsbl. 2010;53:357-88.
17. Zitella LJ, Friese CR, Hauser J, Holmes Gobel B, Woolery M, O'Leary C, et al. Putting evidence into practice: prevention of infection. Clin J Oncol Nurs. 2006;10(6):739-50.
18. U.S. Department of Agriculture Food safety of people with cancer. http://www.fsis.usda.gov/PDF/Food_Safety_for_People_with_Cancer.pdf. Accessed November 14, 2011.
19. U.S. Food and Drug Administration (FDA) Raw milk may pose health risk. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm232980.htm Accessed November 18, 2011.